Linezolid - 23/08/11
Résumé |
Generic and additional names: Linezolid
CAS name: N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide
CAS registry #: 165800-03-3
Molecular formula: C16H20FN3O4
Molecular weight: 337.35
Intellectual property rights: Pfizer
Brand names: Zyvox, Zyvoxid (Pfizer)
Derivatives: Dong-A Pharmaceutical has reported several new oxazolidinones (DA-7157, DA-7218 and DA-7867) having somewhat improved in-vitro potency, compared to linezolid, against Mycobacterium tuberculosis, M. kansasii and M. marinum1,2
Solubility: In water up to 3 mg/ml [DrugBank]
Polarity: Log P 0.232 [DrugBank]
Melting point: 181.5 182.5ºC [Merck Index]
Formulation and optimal human dosage: Zyvox tablets for oral administration contain 400 mg or 600 mg linezolid.
Zyvox i.v. injection is supplied as a 2 mg/ml isotonic solution for intravenous infusion.
Doses: oral or i.v. 600 mg every 12 hours for serious infections and 400 mg every 12 hours for uncomplicated infection [FDA label].
Vol 88 - N° 2
P. 122-125 - mars 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?